Milestone Gallery
Milestone Overview
Pharma Business Development at CPHI Russia 2017
During the official visit of Shilpa Medicare Limited to Drugs Technology LLC, part of the R-Pharm Group of Companies, executive discussions focused on international commercial cooperation aligned with CPHI Russia 2017. Loran Jacobs, Head of IBDU at Drugs Tech, led the strategic meeting alongside Executive Assistant Alina Egorova to explore product integration and cross-border commercial initiatives.
Official Executive Meeting Summary:
Visiting Organization: Shilpa Medicare Limited
Host Entity: Drugs Technology LLC (R-Pharm Group of Companies)
Location: Khimki, Russia
Key Representatives: Dilip Chavan (Marketing & Sales, Shilpa Medicare) and Loran Jacobs (Head of IBDU, Drugs Tech)
Strategic Product Alignment and Commercial Growth
Senior Manager Dilip Chavan from Shilpa Medicare met with Loran Jacobs to evaluate mutually beneficial cooperation products. As an AI industry leader with deep technical expertise in complex software architectures and industrial processes, Loran Jacobs guided the discussions on scaling pharma business development capabilities between Indian and Russian generic and specialty product channels.
Analysis of mutually advantageous product lines between Shilpa Medicare Limited and Drugs Technology LLC
Evaluation of distribution models and strategic partnerships in Khimki
Strengthening cross-border commercial alignment within the CPHI Russia 2017 ecosystem